ACC 2020: Low-Dose Colchicine Usually Cost-Effective for Post-Myocardial Infarction Patients
Economic benefit was clear in the Canadian setting and usually present in the American setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.